Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice
Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF...
Saved in:
| Published in | Frontiers in aging neuroscience Vol. 16; p. 1401038 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1663-4365 1663-4365 |
| DOI | 10.3389/fnagi.2024.1401038 |
Cover
| Abstract | Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF in ischemic stroke is a subject of controversy. Here, we utilized a recently emerging RNA-targeting CRISPR system known as CasRx, delivered by AAVs, to knockdown
Ripk1
mRNA and
Nsf
mRNA around the ischemic brain tissue. This approach resulted in a reduction in infarct and edema volume, as well as an improvement in neurological deficits assessed by Bederson score, RotaRod test, and Adhesive removal test, which were achieved by RIPK1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein signaling pathway involved in neuronal necroptosis. In conclusion, the downregulation of
Ripk1
mRNA and
Nsf
mRNA mediated by CRISPR-CasRx holds promise for future therapeutic applications aimed at ameliorating cerebral lesions and neurological deficits following the ischemic stroke. |
|---|---|
| AbstractList | Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF in ischemic stroke is a subject of controversy. Here, we utilized a recently emerging RNA-targeting CRISPR system known as CasRx, delivered by AAVs, to knockdown
Ripk1
mRNA and
Nsf
mRNA around the ischemic brain tissue. This approach resulted in a reduction in infarct and edema volume, as well as an improvement in neurological deficits assessed by Bederson score, RotaRod test, and Adhesive removal test, which were achieved by RIPK1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein signaling pathway involved in neuronal necroptosis. In conclusion, the downregulation of
Ripk1
mRNA and
Nsf
mRNA mediated by CRISPR-CasRx holds promise for future therapeutic applications aimed at ameliorating cerebral lesions and neurological deficits following the ischemic stroke. Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF in ischemic stroke is a subject of controversy. Here, we utilized a recently emerging RNA-targeting CRISPR system known as CasRx, delivered by AAVs, to knockdown Ripk1 mRNA and Nsf mRNA around the ischemic brain tissue. This approach resulted in a reduction in infarct and edema volume, as well as an improvement in neurological deficits assessed by Bederson score, RotaRod test, and Adhesive removal test, which were achieved by RIPK1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein signaling pathway involved in neuronal necroptosis. In conclusion, the downregulation of Ripk1 mRNA and Nsf mRNA mediated by CRISPR-CasRx holds promise for future therapeutic applications aimed at ameliorating cerebral lesions and neurological deficits following the ischemic stroke.Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF in ischemic stroke is a subject of controversy. Here, we utilized a recently emerging RNA-targeting CRISPR system known as CasRx, delivered by AAVs, to knockdown Ripk1 mRNA and Nsf mRNA around the ischemic brain tissue. This approach resulted in a reduction in infarct and edema volume, as well as an improvement in neurological deficits assessed by Bederson score, RotaRod test, and Adhesive removal test, which were achieved by RIPK1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein signaling pathway involved in neuronal necroptosis. In conclusion, the downregulation of Ripk1 mRNA and Nsf mRNA mediated by CRISPR-CasRx holds promise for future therapeutic applications aimed at ameliorating cerebral lesions and neurological deficits following the ischemic stroke. Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF in ischemic stroke is a subject of controversy. Here, we utilized a recently emerging RNA-targeting CRISPR system known as CasRx, delivered by AAVs, to knockdown Ripk1 mRNA and Nsf mRNA around the ischemic brain tissue. This approach resulted in a reduction in infarct and edema volume, as well as an improvement in neurological deficits assessed by Bederson score, RotaRod test, and Adhesive removal test, which were achieved by RIPK1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein signaling pathway involved in neuronal necroptosis. In conclusion, the downregulation of Ripk1 mRNA and Nsf mRNA mediated by CRISPR-CasRx holds promise for future therapeutic applications aimed at ameliorating cerebral lesions and neurological deficits following the ischemic stroke. Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein kinase 1 (RIPK1) and N-ethylmaleimide-sensitive fusion ATPase (NSF) in initiating necroptosis remains poorly understood, and the role of NSF in ischemic stroke is a subject of controversy. Here, we utilized a recently emerging RNA-targeting CRISPR system known as CasRx, delivered by AAVs, to knockdown mRNA and mRNA around the ischemic brain tissue. This approach resulted in a reduction in infarct and edema volume, as well as an improvement in neurological deficits assessed by Bederson score, RotaRod test, and Adhesive removal test, which were achieved by RIPK1/receptor-interacting protein kinase 3/mixed lineage kinase domain-like protein signaling pathway involved in neuronal necroptosis. In conclusion, the downregulation of mRNA and mRNA mediated by CRISPR-CasRx holds promise for future therapeutic applications aimed at ameliorating cerebral lesions and neurological deficits following the ischemic stroke. |
| Author | Liu, Fei Wang, Yuye Chen, Leian Peng, Dantao Song, Xincheng Lu, Tao Lan, Yang Lv, Shuang |
| Author_xml | – sequence: 1 givenname: Xincheng surname: Song fullname: Song, Xincheng – sequence: 2 givenname: Yang surname: Lan fullname: Lan, Yang – sequence: 3 givenname: Shuang surname: Lv fullname: Lv, Shuang – sequence: 4 givenname: Yuye surname: Wang fullname: Wang, Yuye – sequence: 5 givenname: Leian surname: Chen fullname: Chen, Leian – sequence: 6 givenname: Tao surname: Lu fullname: Lu, Tao – sequence: 7 givenname: Fei surname: Liu fullname: Liu, Fei – sequence: 8 givenname: Dantao surname: Peng fullname: Peng, Dantao |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38919602$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkc9u1DAQhy3UipbSF-CAfOSSxf-SOEe0lLJSBdUWztbEHi9uk3ixE6Cv0Kcm3d1W9cWW_c1vNP7ekKMhDkjIO84WUurmox9gExaCCbXginEm9StyyqtKFkpW5dGL8wk5z_mWzUtKxkr9mpzMAbypmDglD5_j3yHhZupgDHGg0dN12N5xCoOj37KnPboAIzra3tPlenVzvS6WkNf_KPTYhZjmt0zzmOId0j-xm3rclQ44pdjFTbDQUYc-2DBmCn7EREO2v7AP8FQWBtoHi2_JsYcu4_lhPyM_v1z8WH4trr5frpafrgorKzUWVjvkTFeoK-6wVi2CUi2v_DxaVXqunbDgJfiy5MJK2Spva1HWIEqnRe3lGVntc12EW7NNoYd0byIEs7uIaWMgjcF2aBSWoi2VQM65Us422CjU6FvGaqmkmLM-7LO2Kf6eMI-mn6fDroMB45SNZLUQjdCCz-j7Azq186c-N35yMQNiD9gUc07onxHOzKNzs3NuHp2bg3P5H4han9Y |
| Cites_doi | 10.1016/j.cell.2013.03.030 10.14336/AD.2018.0728 10.1016/j.cub.2020.10.059 10.1016/s0166-2236(03)00210-8 10.1016/j.neuroscience.2004.07.025 10.1038/cdd.2012.90 10.1126/science.aat5011 10.1038/nmeth854 10.3390/antiox10091347 10.1038/nature24049 10.1038/s41467-019-13873-0 10.1007/s12975-017-0571-1 10.1007/s12975-017-0572-0 10.1038/nbt831 10.1016/j.immuni.2009.01.001 10.1038/cddis.2012.176 10.1016/s0092-8674(03)00521-x 10.1186/s13059-023-02852-w 10.1002/advs.202206517 10.1124/mol.104.004275 10.1002/advs.201901299 10.1016/j.expneurol.2021.113827 10.1038/cdd.2012.133 10.1038/nbt.4192 10.1126/science.aaq0180 10.1073/pnas.2219091120 10.1016/j.cell.2018.02.033 10.1038/ncomms15464 10.1111/acel.13512 10.1038/s41418-018-0060-4 10.1126/science.aba7365 10.1038/nchembio711 10.1126/science.aag2590 10.1186/s40779-022-00383-2 10.1523/jneurosci.5099-04.2005 10.1161/STROKEAHA.119.026652 10.1016/j.biopha.2017.09.063 10.1006/mcne.2000.0959 10.7554/eLife.05682 10.1038/jcbfm.1981.6 10.1161/CIR.0000000000001123 10.1038/s41419-020-02770-w |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Song, Lan, Lv, Wang, Chen, Lu, Liu and Peng. |
| Copyright_xml | – notice: Copyright © 2024 Song, Lan, Lv, Wang, Chen, Lu, Liu and Peng. |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.3389/fnagi.2024.1401038 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1663-4365 |
| ExternalDocumentID | oai_doaj_org_article_4e52b542e11144dc9e94e8efb0073432 38919602 10_3389_fnagi_2024_1401038 |
| Genre | Journal Article |
| GroupedDBID | --- 53G 5VS 7X7 88I 8FE 8FH 8FI 8FJ 9T4 AAFWJ AAYXX ABIVO ABUWG ACGFO ACGFS ACXDI ADBBV ADRAZ AEGXH AENEX AFKRA AFPKN AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK DWQXO E3Z EIHBH F5P FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE KQ8 LK8 M2P M48 M7P M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM TR2 UKHRP IPNFZ NPM RIG 7X8 PQGLB PUEGO |
| ID | FETCH-LOGICAL-c364t-c8de1086e861de74bea44b16f05865f18d2caf3af5512c33b4fc7257a25d827f3 |
| IEDL.DBID | M48 |
| ISSN | 1663-4365 |
| IngestDate | Wed Aug 27 01:29:27 EDT 2025 Thu Sep 04 19:15:09 EDT 2025 Thu Apr 03 07:08:16 EDT 2025 Tue Jul 01 02:20:53 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | NSF ripk1 CRISPR-CasRx AAV ischemic stroke |
| Language | English |
| License | Copyright © 2024 Song, Lan, Lv, Wang, Chen, Lu, Liu and Peng. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c364t-c8de1086e861de74bea44b16f05865f18d2caf3af5512c33b4fc7257a25d827f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnagi.2024.1401038 |
| PMID | 38919602 |
| PQID | 3072292821 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4e52b542e11144dc9e94e8efb0073432 proquest_miscellaneous_3072292821 pubmed_primary_38919602 crossref_primary_10_3389_fnagi_2024_1401038 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-00-00 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – year: 2024 text: 2024-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in aging neuroscience |
| PublicationTitleAlternate | Front Aging Neurosci |
| PublicationYear | 2024 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Degterev (ref8) 2013; 20 Mohammed (ref22) 2021; 20 Chen (ref5) 2018; 25 Zhang (ref41) 2020; 11 Zhan (ref39) 2023; 24 Ralph (ref23) 2001; 17 Wang (ref31) 2020; 11 Zhang (ref40) 2013; 153 Bale (ref2) 2021; 31 Stadtmauer (ref26) 2020; 367 Tsao (ref30) 2023; 147 Konermann (ref14) 2018; 173 Degterev (ref7) 2005; 1 Geng (ref10) 2017; 95 Jouan-Lanhouet (ref12) 2012; 19 Cox (ref6) 2017; 358 Jackson (ref11) 2003; 21 Knott (ref13) 2018; 361 Wang (ref33) 2015; 4 Li (ref17) 2023; 10 Birmingham (ref4) 2006; 3 Zou (ref42) 2005; 25 Li (ref18) 2023; 120 Wang (ref32) 2019; 6 Krishtal (ref16) 2003; 26 Shin (ref25) 2017; 8 Zeng (ref38) 2022; 9 Yuan (ref34) 2021; 345 Ransohoff (ref24) 2016; 353 Liu (ref19) 2004; 128 Strasser (ref27) 2009; 30 Yuan (ref35); 9 Yuk (ref37) 2021; 10 Matsushita (ref20) 2005; 67 Tamura (ref29) 1981; 1 Abudayyeh (ref1) 2017; 550 Deng (ref9) 2019; 10 Bieber (ref3) 2019; 50 Takahashi (ref28) 2012; 3 Micheau (ref21) 2003; 114 Kosicki (ref15) 2018; 36 Yuan (ref36); 9 |
| References_xml | – volume: 153 start-page: 707 year: 2013 ident: ref40 article-title: Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease publication-title: Cell doi: 10.1016/j.cell.2013.03.030 – volume: 10 start-page: 807 year: 2019 ident: ref9 article-title: Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3/MLKL signaling publication-title: Aging Dis. doi: 10.14336/AD.2018.0728 – volume: 31 start-page: 473 year: 2021 ident: ref2 article-title: Sequence learning induces selectivity to multiple task parameters in mouse somatosensory cortex publication-title: Curr. Biol. doi: 10.1016/j.cub.2020.10.059 – volume: 26 start-page: 477 year: 2003 ident: ref16 article-title: The ASICs: signaling molecules? Modulators? publication-title: Trends Neurosci. doi: 10.1016/s0166-2236(03)00210-8 – volume: 128 start-page: 767 year: 2004 ident: ref19 article-title: Alterations of N-ethylmaleimide-sensitive atpase following transient cerebral ischemia publication-title: Neuroscience doi: 10.1016/j.neuroscience.2004.07.025 – volume: 19 start-page: 2003 year: 2012 ident: ref12 article-title: TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation publication-title: Cell Death Differ. doi: 10.1038/cdd.2012.90 – volume: 361 start-page: 866 year: 2018 ident: ref13 article-title: CRISPR-Cas guides the future of genetic engineering publication-title: Science doi: 10.1126/science.aat5011 – volume: 3 start-page: 199 year: 2006 ident: ref4 article-title: 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets publication-title: Nat. Methods doi: 10.1038/nmeth854 – volume: 10 start-page: 1347 year: 2021 ident: ref37 article-title: Necrostatin-1 prevents Ferroptosis in a RIPK1- and IDO-independent manner in hepatocellular carcinoma publication-title: Antioxidants doi: 10.3390/antiox10091347 – volume: 550 start-page: 280 year: 2017 ident: ref1 article-title: RNA targeting with CRISPR-Cas13 publication-title: Nature doi: 10.1038/nature24049 – volume: 11 start-page: 475 year: 2020 ident: ref31 article-title: Disruption of auto-inhibition underlies conformational signaling of ASIC1a to induce neuronal necroptosis publication-title: Nat. Commun. doi: 10.1038/s41467-019-13873-0 – volume: 9 start-page: 201 ident: ref36 article-title: Inactivation of NSF ATPase leads to Cathepsin B release after transient cerebral ischemia publication-title: Transl. Stroke Res. doi: 10.1007/s12975-017-0571-1 – volume: 9 start-page: 215 ident: ref35 article-title: Dysfunction of membrane trafficking leads to ischemia-reperfusion injury after transient cerebral ischemia publication-title: Transl. Stroke Res. doi: 10.1007/s12975-017-0572-0 – volume: 21 start-page: 635 year: 2003 ident: ref11 article-title: Expression profiling reveals off-target gene regulation by RNAi publication-title: Nat. Biotechnol. doi: 10.1038/nbt831 – volume: 30 start-page: 180 year: 2009 ident: ref27 article-title: The many roles of FAS receptor signaling in the immune system publication-title: Immunity doi: 10.1016/j.immuni.2009.01.001 – volume: 3 start-page: e437 year: 2012 ident: ref28 article-title: Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models publication-title: Cell Death Dis. doi: 10.1038/cddis.2012.176 – volume: 114 start-page: 181 year: 2003 ident: ref21 article-title: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes publication-title: Cell doi: 10.1016/s0092-8674(03)00521-x – volume: 24 start-page: 9 year: 2023 ident: ref39 article-title: Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme publication-title: Genome Biol. doi: 10.1186/s13059-023-02852-w – volume: 10 start-page: e2206517 year: 2023 ident: ref17 article-title: Engineered extracellular vesicle-delivered CRISPR/CasRx as a novel RNA editing tool publication-title: Adv Sci doi: 10.1002/advs.202206517 – volume: 67 start-page: 1137 year: 2005 ident: ref20 article-title: A novel class of fusion polypeptides inhibits exocytosis publication-title: Mol. Pharmacol. doi: 10.1124/mol.104.004275 – volume: 6 start-page: 1901299 year: 2019 ident: ref32 article-title: The CRISPR-Cas13a gene-editing system induces collateral cleavage of RNA in glioma cells publication-title: Adv Sci doi: 10.1002/advs.201901299 – volume: 345 start-page: 113827 year: 2021 ident: ref34 article-title: Interruption of endolysosomal trafficking leads to stroke brain injury publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2021.113827 – volume: 20 start-page: 366 year: 2013 ident: ref8 article-title: Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase publication-title: Cell Death Differ. doi: 10.1038/cdd.2012.133 – volume: 36 start-page: 765 year: 2018 ident: ref15 article-title: Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements publication-title: Nat. Biotechnol. doi: 10.1038/nbt.4192 – volume: 358 start-page: 1019 year: 2017 ident: ref6 article-title: RNA editing with CRISPR-Cas13 publication-title: Science doi: 10.1126/science.aaq0180 – volume: 120 start-page: e2219091120 year: 2023 ident: ref18 article-title: Myeloid-derived MIF drives RIPK1-mediated cerebromicrovascular endothelial cell death to exacerbate ischemic brain injury publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2219091120 – volume: 173 start-page: 665 year: 2018 ident: ref14 article-title: Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors publication-title: Cell doi: 10.1016/j.cell.2018.02.033 – volume: 8 start-page: 15464 year: 2017 ident: ref25 article-title: CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome publication-title: Nat. Commun. doi: 10.1038/ncomms15464 – volume: 20 start-page: e13512 year: 2021 ident: ref22 article-title: Necroptosis contributes to chronic inflammation and fibrosis in aging liver publication-title: Aging Cell doi: 10.1111/acel.13512 – volume: 25 start-page: 648 year: 2018 ident: ref5 article-title: Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD publication-title: Cell Death Differ. doi: 10.1038/s41418-018-0060-4 – volume: 367 start-page: 7365 year: 2020 ident: ref26 article-title: CRISPR-engineered T cells in patients with refractory cancer publication-title: Science doi: 10.1126/science.aba7365 – volume: 1 start-page: 112 year: 2005 ident: ref7 article-title: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio711 – volume: 353 start-page: 777 year: 2016 ident: ref24 article-title: How neuroinflammation contributes to neurodegeneration publication-title: Science doi: 10.1126/science.aag2590 – volume: 9 start-page: 25 year: 2022 ident: ref38 article-title: Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis publication-title: Mil. Med. Res. doi: 10.1186/s40779-022-00383-2 – volume: 25 start-page: 4385 year: 2005 ident: ref42 article-title: Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity publication-title: J. Neurosci. doi: 10.1523/jneurosci.5099-04.2005 – volume: 50 start-page: 2875 year: 2019 ident: ref3 article-title: Validity and reliability of neurological scores in mice exposed to middle cerebral artery occlusion publication-title: Stroke doi: 10.1161/STROKEAHA.119.026652 – volume: 95 start-page: 1479 year: 2017 ident: ref10 article-title: Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS/MS and the study of its pharmacokinetics and bioavailability publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.09.063 – volume: 17 start-page: 662 year: 2001 ident: ref23 article-title: Disruption of the GluR2-NSF interaction protects primary hippocampal neurons from ischemic stress publication-title: Mol. Cell. Neurosci. doi: 10.1006/mcne.2000.0959 – volume: 4 start-page: 5682 year: 2015 ident: ref33 article-title: Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction publication-title: eLife doi: 10.7554/eLife.05682 – volume: 1 start-page: 53 year: 1981 ident: ref29 article-title: Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.1981.6 – volume: 147 start-page: e93 year: 2023 ident: ref30 article-title: Heart disease and stroke Statistics-2023 update: a report from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000001123 – volume: 11 start-page: 565 year: 2020 ident: ref41 article-title: Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation publication-title: Cell Death Dis. doi: 10.1038/s41419-020-02770-w |
| SSID | ssj0000330058 |
| Score | 2.3379571 |
| Snippet | Necroptosis is implicated in the pathogenesis of ischemic stroke. However, the mechanism underlying the sequential recruitment of receptor-interacting protein... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 1401038 |
| SubjectTerms | AAV CRISPR-CasRx ischemic stroke NSF ripk1 |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9xADB5KDiGX0kfabh9hArkVN-ux_Dq2m4QkkFC2DeQ2zEMDSxpvWDvQ_oX-6kgz3rCXkkuvxoPH-iSNPsuShDiA2ueVcWVWeK8yUMFnlvxgpqylaNuGygEXOF9cVqdXcH5dXm-M-uJ_wlJ74CS4Q8BS2RIUklECeNdiC9hgsJxjgiJ632k73SBT0QcX3Ia9SVUyxMLaw8BTf4gPKvjCnGLKBSkbJ1Fs2P_vKDOeNicvxPMxTJRf0_ZeimfYvRLbF2Mi_LX4e0TseZXmyJNk5TLI-eLuJpem8_KyDzJWhFA0Ke0fOZuf_fg-z2amn_-W5hZ_cVk-hZiyH1bLG5TJQ8Wlsb3l6A6lR24vMfQyDhKXCyLCeLsw62WLTvIs-11xdXL8c3aajWMVMldUMGSu8cjzlbCpco81WDQANq8CCawqQ9545UwoTKBgSrmisBBcTZZtVOkbVYfijdjqlh2-E9IzBKhM7YwBV5nWuoZIneXsTqitn4jPaxHru9Q9QxPrYEB0BEQzIHoEZCK-MQqPd3Ln63iB9EGP-qCf0oeJ2F9jqMlSOP1hOlze95q8mVItUcx8It4mcB8fxdla4nLq_f_Ywgexw6-VPtR8FFvD6h4_Uegy2L2opQ8-puu7 priority: 102 providerName: Directory of Open Access Journals |
| Title | Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38919602 https://www.proquest.com/docview/3072292821 https://doaj.org/article/4e52b542e11144dc9e94e8efb0073432 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7ygNJL6bvbx6JCb8VpLcmW91BKs02aFrIEtwt7M3qWJYmd2g4kf6G_ujOyN1Bobr34YCxsz2eNvk_jmQF4I5VLc22zRDjHE8mDSwz6wYQbg2zbhNxKSnA-XuRHS_ltla22YNPuaDRg909pR_2klu3Z3tWv64844T-Q4sT19l2ghj4o9bjcI7nwXhTbsBvjRfQr30j3o2cWVJy9GHJnbhn61_oUy_jfzj3jGnR4H-6N5JF9GtB-AFu-fgh3jsfw-CP4_Rk1dTt0l0d7syawcn1xmjJdO7boAot5Isgxmblm8_Lr95MymeuuvGL63J9Rsj4ST9b1bXPq2eC34tBY9HJ0ksx5KjrRdyy2F2drtKE_X-vNsHXNqMP9Y1geHvyYHyVjs4XEilz2iS2cp65LvshT55U0Xktp0jygwfIspIXjVgehA1IsboUwMliF813zzBVcBfEEduqm9s-AOSWk8Fwrq7W0uZ4ZW6DUMxTzCcq4CbzdmLi6GGpqVKhFCJAqAlIRINUIyAT2CYWbK6kedjzRtD-rcXpV0mfcZJJ7dN1SOjvzM-kLHwxFIqXgE3i9wbDC-UNBEV375rKr0MdxPkPhmU7g6QDuza0ohosKjz__H4_wAu7Saw3bNy9hp28v_SskNL2ZwrZaqSns7h8sTspp3BbA45dVOo3f7x_pTfju |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Downregulation+of+Ripk1+and+Nsf+mediated+by+CRISPR-CasRx+ameliorates+stroke+volume+and+neurological+deficits+after+ischemia+stroke+in+mice&rft.jtitle=Frontiers+in+aging+neuroscience&rft.au=Xincheng+Song&rft.au=Xincheng+Song&rft.au=Yang+Lan&rft.au=Shuang+Lv&rft.date=2024&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-4365&rft.volume=16&rft_id=info:doi/10.3389%2Ffnagi.2024.1401038&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4e52b542e11144dc9e94e8efb0073432 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-4365&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-4365&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-4365&client=summon |